4.2 Article

Rheumatic symptoms in childhood leukaemia and lymphoma-a ten-year retrospective study

Journal

PEDIATRIC RHEUMATOLOGY
Volume 11, Issue -, Pages -

Publisher

BMC
DOI: 10.1186/1546-0096-11-20

Keywords

Childhood; Musculoskeletal complaints; Leukaemia; Lymphoma; Juvenile; Idiopathic arthritis

Ask authors/readers for more resources

Background: The initial symptoms of childhood leukaemia and lymphoma are often similar to those of juvenile idiopathic arthritis (JIA). In our study, we analyzed the frequency and characteristics of musculoskeletal complaints as the initial presenting symptoms of newly diagnosed leukaemia and lymphoma patients in the past 10 years in our clinic. Methods: Using the Hungarian Tumour Register, we performed a retrospective analysis of the medical records of 166 new leukaemia and 95 new lymphoma pediatric patients treated from 1999 to 2009 at the 2nd. Dept. of Paediatrics of the Semmelweis University in Budapest. Results: Twenty percent of the leukaemic (33 children) and 2% of the lymphoma patients (2 children) had musculoskeletal symptoms at first presentation. Two-thirds of both groups of patients had other general symptoms like fever and/or fatigue. The hip was the most frequently affected joint (7/33) in the leukaemic patients. Twenty-four percent of all the children had been previously evaluated by an orthopaedist; 12% had visited another rheumatologist prior to diagnosis. Imaging had been done in an unexpectedly low number of patients prior to referral to our unit (radiographs: 16 or 48%, ultrasound: 5 patients or 15%). Radiographs of the affected joints were abnormal in only one case (1/16, 6%). The joint ultrasound was abnormal in only three children of 5 studied (3/5, 60%). Anaemia (26/32, 6%), thrombocytopenia (78%) and LDH elevation (3-4 times the normal count) were frequent in the leukaemic patients. Half of the cases had a normal leukocyte count. The lymphoma group had similar results. Two patients of the leukaemia group received steroid treatment before the final diagnosis. Severe pain out of proportion to physical findings is another clue. Conclusions: Haematologic malignancies must be excluded before initiation of therapy for childhood arthritis among children presenting with musculoskeletal signs and symptoms, particularly in atypical cases. Malignancies are to be suspected when pain is disproportionately severe compared to the physical examination findings, and when anaemia, thrombocytopenia, and an elevated LDH level are present. Diagnosing leukaemia early is important because the use of steroids and immunosuppressive medications may mask and delay its diagnosis. Additionally, pre-treatment of presumed JIA patients with these drugs who eventually are diagnosed to have a malignancy may lead to the malignancy being steroid-resistant and more difficult to treat.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.2
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

Article Oncology

A pharmacokinetic study of lipegfilgrastim in children with Ewing family of tumors or rhabdomyosarcoma

Margarita B. Belogurova, Zoryana P. Kizyma, Miklos Garami, Monika Csoka, Michael J. Lamson, Anton Buchner, Peter Bias, Andreas Lammerich

CANCER CHEMOTHERAPY AND PHARMACOLOGY (2017)

Article Oncology

Pharmacogenetic analysis of high-dose methotrexate treatment in children with osteosarcoma

Marta Hegyi, Adam Arany, Agnes F. Semsei, Katalin Csordas, Oliver Eipel, Andras Gezsi, Nora Kutszegi, Monika Csoka, Judit Muller, Daniel J. Erdelyi, Peter Antal, Csaba Szalai, Gabor T. Kovacs

ONCOTARGET (2017)

Article Oncology

Absolute Lymphocyte Count (ALC) after Induction Treatment Predicts Survival of Pediatric Patients with Acute Lymphoblastic Leukemia

Tamas Farkas, Judit Muller, Daniel J. Erdelyi, Monika Csoka, Gabor T. Kovacs

PATHOLOGY & ONCOLOGY RESEARCH (2017)

Article Oncology

The Presence of ALK Alterations and Clinical Relevance of Crizotinib Treatment in Pediatric Solid Tumors

Luca Felkai, Rita Banusz, Ilona Kovalszky, Zoltan Sapi, Miklos Garami, Gergo Papp, Katalin Karaszi, Edit Varga, Monika Csoka

PATHOLOGY & ONCOLOGY RESEARCH (2019)

Article Rheumatology

The Hungarian version of the Juvenile Arthritis Multidimensional Assessment Report (JAMAR)

Ilonka Orban, Tamas Constantin, Beata Derfalvi, Krisztina Sevcic, Diana Garan, Rita Kaposzta, Gyula Poor, Emese Kiss, Andrea Ponyi, Alessandro Consolaro, Francesca Bovis, Nicolino Ruperto

RHEUMATOLOGY INTERNATIONAL (2018)

Article Immunology

Tolerability of subcutaneous immunoglobulin 20%, Ig20Gly, in pediatric patients with primary immunodeficiencies

Kenneth Paris, Elie Haddad, Michael Borte, Nicholas Brodszki, Beata Derfalvi, Laszlo Marodi, Iftikhar Hussain, Amy Darter, Werner Engl, Heinz Leibl, Barbara McCoy, Leman Yel

IMMUNOTHERAPY (2019)

Article Biotechnology & Applied Microbiology

Quantitative RT-PCR-based miRNA profiling of blastemal Wilms' tumors from formalin-fixed paraffin-embedded samples

Gergely Buglyo, Zsofia Magyar, Eva Romicsne Gorbe, Rita Banusz, Monika Csoka, Tamas Micsik, Zsanett Berki, Peter Varga, Zoltan Sapi, Balint Nagy

JOURNAL OF BIOTECHNOLOGY (2019)

Article Multidisciplinary Sciences

Highly efficient serum-free manipulation of miRNA in human NK cells without loss of viability or phenotypic alterations is accomplished with TransIT-TKO

Breanna K. V. Hargreaves, Sarah E. Roberts, Beata Derfalvi, Jeanette E. Boudreau

PLOS ONE (2020)

Article Oncology

Characterization of mTOR Activity and Metabolic Profile in Pediatric Rhabdomyosarcoma

Luca Felkai, Ildiko Krencz, Dorottya Judit Kiss, Noemi Nagy, Gabor Petovari, Titanilla Danko, Tamas Micsik, Andras Khoor, Tamas Tornoczky, Zoltan Sapi, Anna Sebestyen, Monika Csoka

CANCERS (2020)

Article Allergy

Rituximab-induced hypogammaglobulinemia and infection risk in pediatric patients

Roxane Labrosse, Sara Barmettler, Beata Derfalvi, Annaliesse Blincoe, Guilhem Cros, Jonathan Lacombe-Barrios, Julie Barsalou, Nancy Yang, Nora Alrumayyan, Jan Sinclair, Mei-Sing Ong, Carlos A. Camargo, Jolan Walter, Elie Haddad

Summary: The study revealed a high prevalence of hypogammaglobulinemia in children receiving rituximab treatment, with low IgG levels associated with an increased risk of serious infections. Underlying primary immunodeficiencies were relatively common in pediatric patients receiving rituximab.

JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY (2021)

Article Immunology

High Dose Intravenous IgG Therapy Modulates Multiple NK Cell and T Cell Functions in Patients With Immune Dysregulation

Sarah M. McAlpine, Sarah E. Roberts, John J. Heath, Fabian Kasermann, Andrew C. Issekutz, Thomas B. Issekutz, Beata Derfalvi

Summary: IVIG treatment has multiple effects on NK cell subsets and CD4(+) T cells, promoting resolution of inflammation in patients with immune dysregulation.

FRONTIERS IN IMMUNOLOGY (2021)

Review Allergy

COVID-19 vaccine testing & administration guidance for allergists/immunologists from the Canadian Society of Allergy and Clinical Immunology (CSACI)

Timothy K. Vander Leek, Edmond S. Chan, Lori Connors, Beata Derfalvi, Anne K. Ellis, Julia E. M. Upton, Elissa M. Abrams

Summary: This review discusses the safety concerns of COVID-19 vaccines for individuals with allergies and immunocompromised conditions, emphasizing the need for assessment by allergists. It also provides guidance on when COVID-19 vaccines should be offered to immunocompromised patients, with updates to this guidance expected as new information becomes available.

ALLERGY ASTHMA AND CLINICAL IMMUNOLOGY (2021)

Article Pediatrics

Joint involvement, disease activity and quality of life in pediatric Crohn's disease - a cross-sectional study

Beata Derfalvi, Kriszta Katinka Boros, Doloresz Szabo, Gabor Bozsaki, Aron Cseh, Gabor Rudas, Katalin Eszter Muller, Gabor Veres

Summary: This study provides new data on the prevalence of joint involvement in pediatric CD and its correlation with disease activity and quality of life. The results show that joint involvement is more prevalent in pediatric CD than previously reported and is associated with more severe disease activity and lower quality of life.

PEDIATRIC RHEUMATOLOGY (2022)

Article Allergy

Prolidase deficiency, a rare inborn error of immunity, clinical phenotypes, immunological features, and proposed treatments in twins

Nora Alrumayyan, Drew Slauenwhite, Sarah M. McAlpine, Sarah Roberts, Thomas B. Issekutz, Adam M. Huber, Zaiping Liu, Beata Derfalvi

Summary: Prolidase deficiency is a multisystemic disease that can lead to immune dysregulation and metabolic defects. We report detailed case presentations of twin females with Prolidase deficiency, including their immunological characteristics and treatment modalities.

ALLERGY ASTHMA AND CLINICAL IMMUNOLOGY (2022)

Article Allergy

X-linked agammaglobulinemia (XLA): Phenotype, diagnosis, and therapeutic challenges around the world

Zeinab A. El-Sayed, Irina Abramova, Juan Carlos Aldave, Waleed Al-Herz, Liliana Bezrodnik, Rachida Boukari, Ahmed Aziz Bousfiha, Caterina Cancrini, Antonio Condino-Neto, Ghassan Dbaibo, Beata Derfalvi, Figen Dogu, J. David M. Edgar, Brian Eley, Rasha Hasan El-Owaidy, Sara Elva Espinosa-Padilla, Nermeen Galal, Filomeen Haerynck, Rima Hanna-Wakim, Elham Hossny, Aydan Ikinciogullari, Ebtihal Kamal, Hirokazu Kanegane, Nadia Kechout, Yu Lung Lau, Tomohiro Morio, Viviana Moschese, Joao Farela Neves, Monia Ouederni, Roberto Paganelli, Kenneth Paris, Claudio Pignata, Alessandro Plebani, Farah Naz Qamar, Sonia Qureshi, Nita Radhakrishnan, Nima Rezaei, Nelson Rosario, John Routes, Berta Sanchez, Anna Sediva, Mikko R. J. Seppanen, Edith Gonzalez Serrano, Anna Shcherbina, Surjit Singh, Sangeetha Siniah, Guiseppe Spadaro, Mimi Tang, Ana Maria Vinet, Alla Volokha, Kathleen E. Sullivan

WORLD ALLERGY ORGANIZATION JOURNAL (2019)

No Data Available